ライフサイエンスコーパス: body fluid

1 lar fractions, protein complexes, tissues or body fluids).

2 's modified eagle medium (DMEM) or simulated body fluid.

3 ion of all Abeta peptides extracted from the body fluid.

4 ature of the equilibrium between mineral and body fluid.

5 d for consent to culture their child's blood/body fluid.

6 d by an anomalous nitrogen-containing parent body fluid.

7 eutical formulations, biological tissues and body fluid.

8 vant changes in low-abundance metabolites in body fluid.

9 em and a gradual release in pH 7.4 simulated body fluid.

10 rast to blood, whole saliva is a non-sterile body fluid.

11 us materials have degradability in simulated body fluid.

12 esonance imaging) and biochemical markers in body fluid.

13 pneumococcus in a relevant normally sterile body fluid.

14 blood group antigens are found in non-blood body fluids.

15 ary transmission due to viral persistence in body fluids.

16 with previously described exosomes in other body fluids.

17 linked to the biochemical compounds in their body fluids.

18 imarily transmitted by contact with infected body fluids.

19 al stimuli are typically secreted in various body fluids.

20 for early and efficient diagnosis from human body fluids.

21 hes the typical range of EV concentration in body fluids.

22 malignant or benign lesions), cell lines and body fluids.

23 ading to their elevated levels in breath and body fluids.

24 urotransmitters in the presence of simulated body fluids.

25 overy from scarce samples of human tissue or body fluids.

26 by various cells and are found in many human body fluids.

27 is highly correlated to their solubility in body fluids.

28 those introduced to swimming pools via human body fluids.

29 that induce the formation of mineral NPs in body fluids.

30 that affect the viscosity of blood or other body fluids.

31 been shown to be differentially expressed in body fluids.

32 bind tightly and specifically to proteins in body fluids.

33 d generated a new reagent to recognize it in body fluids.

34 been reported following exposure to blood or body fluids.

35 erate the formation of ice crystals in their body fluids.

36 the SOMAmers with their cognate proteins in body fluids.

37 rvesting, concentration, and preservation in body fluids.

38 ly relevant concentrations in the respective body fluids.

39 ed for rapid biomolecule quantification from body fluids.

40 croRNA (miRNA) detection and quantitation in body fluids.

41 physiological roles found in all tissues and body fluids.

42 ons found in serum, sweat, saliva, and other body fluids.

43 pivotal role in regulating the osmolality of body fluids.

44 of protein complexes, protein secretion and body fluids.

45 ool for diagnosis of unknown infections from body fluids.

46 000 samples of human cell lines, tissues and body fluids.

47 s due to their high stability in tissues and body fluids.

48 fragments are present in various tissues and body fluids.

49 ransmission should aim to reduce exposure to body fluids.

50 ty of samples, including cells, tissues, and body fluids.

51 biquitous in human tissues, circulation, and body fluids.

52 measure viral burden in various tissues and body fluids.

53 y different d/l-cysteine ratios in simulated body fluids.

54 13; 95% CI, 2.6 to 62) and with exposure to body fluids (adjusted odds ratio, 4.3; 95% CI, 1.6 to 11

55 n innovative sensing principles, alternative body fluids, advanced flexible materials, and novel plat

56 e of infection and daily production of these body fluids, an infected deer would shed thousands of pr

57 ow that local renal circadian clocks control body fluid and BP homeostasis.

58 Apelin plays a prominent role in body fluid and cardiovascular homeostasis.

59 Simulated body fluid and cell culture tests indicated favorable bi

60 play an important role in the maintenance of body fluid and electrolyte balance and pH homeostasis.

61 rces determining the compartmentalization of body fluid and its movement across capillary and cell me

62 until the loss of ZIKV RNA detection in each body fluid and reported the findings in medians and 95th

63 Future studies will expand to other body fluids and additional donor characteristics, such a

64 cells, likely to allow the rapid control of body fluids and BP through both contractile and endocrin

65 curs primarily through contact with infected body fluids and can result in major epidemics in under-r

66 e resistant to inhibitory factors present in body fluids and effectively inhibit formation of fungal

67 not yet been described in tissues apart from body fluids and erythrocytes.

68 camera, which is routinely compromised when body fluids and fogging occlude the lens, requiring leng

69 (cfmtDNA) is detectable in almost all human body fluids and has been associated with the onset and p

70 healthcare personnel (HCP) and patients from body fluids and infectious organisms via contact, drople

71 and quantify) exogenous GHB in almost intact body fluids and its high potential in the search for met

72 bile iron in pharmaceutical preparations and body fluids and its potential toxic role as a pathogenic

73 By moving essential body fluids and molecules, motile cilia and flagella gov

74 assembly of proteins found in the blood and body fluids and on cell surfaces.

75 rate the presence of extracellular miRNAs in body fluids and propose the involvement of miRNAs in cel

76 lationship between the presence of toxins in body fluids and systemic manifestations of CDI.

77 e to microgravity alters the distribution of body fluids and the degree of distension of cranial bloo

78 ty in which misfolded proteins accumulate in body fluids and the placenta.

79 e sampling (MITS) to gather small samples of body fluids and tissue from the bodies of children who h

80 red them clinically with sampling of various body fluids and tissues for nearly 3 months.

81 ight microscopic identification of spores in body fluids and tissues, using a variety of stains.

82 lysis, and understanding of metabotypes from body fluids and tissues.

83 for the infield identification of traces of body fluids and to obtain phenotypic information about t

84 ransmitted through sexual contact, nonsexual body fluids, and perinatally.

85 olating EVs from both cell-culture media and body fluids, and procedures for quantifying EVs.

86 analyses of GAGs have focused on cell lines, body fluids, and relatively large tissue samples.

87 demonstrate the presence of toxins in feces, body fluids, and serum and a significant elevation in in

88 s included adverse events, viral shedding in body fluids, and vector antibody responses.

89 nerate peptide mixtures from urine and other body fluids are critical to increase cost-effectiveness

90 Enzyme activities in body fluids are often used as diagnostic markers for phy

91 lls can utilize the dissolved glucose in the body fluid as fuel.

92 limit to sense glucose concentration in the body fluids as well as the human blood that can be presu

93 nd they prove to be very stable in simulated body fluid at physiological temperature.

94 s) play an indispensable role in maintaining body fluid balance partly through their ability to regul

95 Estrogens affect body fluid balance, including sodium ingestion.

96 inotropic/vasotropic actions and to optimize body fluid balance, this candidate pathway might benefit

97 ociated with a fall in insulin secretion and body fluid balance.

98 ve determination of antidepressants in human body fluids because of the present scenario of rising de

99 ioelectronic implants such as dissolution in body fluids, biocompatibility, mechanical properties and

100 unt (iii) material type and (iv) exposure to body fluids (blood or synovial fluid) on release kinetic

101 ection of these low-abundant biomolecules in body fluids (blood, urine, and saliva) is emerging in cu

102 ies of 12 patients with culture/PCR-negative body fluids but for whom an infectious diagnosis was ult

103 This yeast may grow freely in body fluids, but it also flourishes within host cells.

104 Long noncoding RNAs are present in body fluids, but their potential as biomarkers was never

105 des) in extracts of food, plant tissues, and body fluids by coupling the method to a high-throughput

106 are small membranous vesicles secreted into body fluids by multiple cell types, including tumor cell

107 The virions in body fluids can be opsonized with complement factors bec

108 Body fluids can easily be identified, and DNA analysis c

109 Body fluids capture features of the dominant lineage, an

110 ventricular organs and in hindbrain putative body fluid/cardiovascular regulatory regions is affected

111 applications, such as human identification, body fluid characterization, postmortem interval estimat

112 Homeostatic control of body fluid CO(2) is essential in animals but is poorly u

113 ial function of maintaining the constancy of body fluid composition and volume.

114 g" transporters maintain effective organ and body fluid concentrations of key nutrients, signaling mo

115 Semen is a complex body fluid containing many factors that may facilitate o

116 us detection of multiple tumor biomarkers in body fluids could facilitate early diagnosis of lung can

117 uble immune checkpoint markers expression in body fluids could potentially be a better alternative.

118 Biomarkers found in blood or other body fluids could supplement current clinical indicators

119 la virus RNA has been noted in the following body fluids days or months after onset of illness: saliv

120 e isotopic concentrations in the tissues and body fluids depending on their dietary habits.

121 escein release and pre-coating of beads with body fluids did not affect short-term release or antibac

122 Body fluid DNA sequencing is a powerful noninvasive appr

123 to elucidate phenotypic information about a body fluid donor.

124 ermine externally visible characteristics of body fluid donors have been developed in recent years.

125 essential virulence factor and is shed into body fluids during a murine model of pulmonary anthrax.

126 stent with time-dependent decay of cells and body fluids during incubation ex vivo.

127 Newer work now supports an evolving model of body fluid dynamics that integrates exchangeable Na(+) s

128 KA) and branched-chain amino acids (BCAA) in body fluids (e.g. keto-isocaproic acid from the BCAA leu

129 sease-associated, cell-free nucleic acids in body fluids enables early diagnostics, genotyping and pe

130 he stable properties of HLC and hBMP2 in the body fluid environment with good biocompatibility and no

131 erating room nurses did not report blood and body fluid exposures (60.9%).

132 Of these 1270 had experience with blood and body fluid exposures (62.5%).

133 or inadequate actions taken after blood and body fluid exposures place individuals at risk for infec

134 n 8%, persons who are the source of blood or body fluid exposures that might warrant postexposure pro

135 infected individuals shed the virus in their body fluids following reactivation from latently infecte

136 r most complex but also the most interesting body fluid for cardiovascular research.

137 ntinuously screen for biochemical markers in body fluids for the prognosis, diagnosis and management

138 on can also produce NO, predominantly within body fluids (for example, saliva, sweat and blood plasma

139 The performance of mNGS testing of 182 body fluids from 160 patients with acute illness was eva

140 reutzfeldt-Jakob disease prions circulate in body fluids from people in whom the disease is silently

141 Detection of microbial nucleic acids in body fluids has become the preferred method for rapid di

142 ation of flowing cells and particulates from body fluids has enormous implications in diagnosis, moni

143 Proteomic analysis of cells, tissues and body fluids has generated valuable insights into the com

144 The forensic analysis of body fluids has made great strides in recent years.

145 the source(s) of infectious prions in these body fluids has yet to be identified.

146 eopontin (OPN), a protein present in several body fluids, has been suggested as a potential biomarker

147 Their isolation and analysis from body fluids have a great clinical potential to provide i

148 extracellular vesicles (sEVs) circulating in body fluids holds potentials in noninvasive diagnosis of

149 nd are emerging as an important regulator of body fluid homeostasis and cardiovascular functions.

150 the lamina terminalis neurons to coordinate body fluid homeostasis and contribute to disorders of fl

151 systems for regulation of cardiovascular and body fluid homeostasis in pregnant animals.

152 y to respond to a physiological challenge to body fluid homeostasis may be compromised following RDN.

153 ody fluid homeostasis.SIGNIFICANCE STATEMENT Body fluid homeostasis requires the integration of neuro

154 portant roles in maintaining renal function, body fluid homeostasis, and blood pressure.

155 versus osmolarity and subsequently regulate body fluid homeostasis.

156 play an essential role in the regulation of body fluid homeostasis.

157 two major neurohumoral signals that regulate body fluid homeostasis.

158 renin-angiotensin system, a key modulator of body fluid homeostasis.

159 d both NaCl and AngII to regulate thirst and body fluid homeostasis.

160 AngII concentrations to regulate thirst and body fluid homeostasis.SIGNIFICANCE STATEMENT Body fluid

161 Body fluid hyperosmolality has long been known to elicit

162 and sympathetic nervous system responses to body fluid hyperosmolality.

163 The miRNA-based body fluid identification assays were highly specific be

164 provide a promising alternative approach to body fluid identification for forensic casework.

165 roposed to supplant conventional methods for body fluid identification.

166 by positive culture from a wound or sterile body fluid (ie, blood, cerebrospinal fluid) and at least

167 gical signals, body motions, and analysis of body fluids, (ii) smart gloves and prosthetics to realis

168 Ebola-positive body fluid-impregnated cotton pads were serially sampled

169 Water, the major body fluid in humans, has four main naturally occurring

170 ungal capsular polysaccharides are shed into body fluids in large amounts during infection.

171 levels are detected in human serum and other body fluids in several inflammatory conditions.

172 ble to detect single virus particle in human body fluids in the near future.

173 e to mass spectrometry because they exist in body fluids in very low concentrations, are masked by hi

174 les by sample type, focusing on sensing from body fluids in vitro and on wearable sensors, which have

175 Fn is found in almost all body fluids, in the extracellular matrix, and plays a fu

176 Although EVs are found in all body fluids, in this review, we will focus on EVs from h

177 oteins that inhibit ectopic calcification in body fluids, including albumin, fetuin-A, and apolipopro

178 alpha-Syn is present in human body fluids, including blood plasma, and is a potential

179 from cells and are present in virtually all body fluids, including blood, urine, saliva, sweat, and

180 Detection of fungal antigens in body fluids, including cryptococcus capsular polysacchar

181 ction is low.Zika virus (ZIKV) is present in body fluids, including saliva, but transmission risk thr

182 etections of important biomarkers in various body fluids, including urine, saliva, serum, and whole b

183 Conversely, the loss of body fluid induces hypovolaemic thirst, in which animals

184 concentration of biologically active MBL in body fluids is an indicator of proper function of the MB

185 the transmission risk associated with these body fluids is currently unknown.

186 te to maintain proteostasis in extracellular body fluids is limited, but it has significantly advance

187 The use of mRNA for the identification of body fluids is of particular interest in forensic scienc

188 Abnormal level of serotonin (ST) in body fluids is related to various clinical conditions in

189 ncer biomarkers detectable in blood or other body fluids less invasively and more cheaply than using

190 The current literature on body fluid levels of GFAP in human disease is summarised

191 of drugs and/or their metabolites in complex body fluids like plasma.

192 is expressed in airway epithelial cells and body fluids like saliva, tear film, ear fluid, and breas

193 Pathogens that traffic in blood and other body fluids, like Borreliella, have evolved means to eva

194 s, HAT-L4-deficient newborn mice had greater body fluid loss and higher mortality in a trans-epiderma

195 ss and higher mortality in a trans-epidermal body fluid loss test.

196 ant in epidermal barrier function to prevent body fluid loss.

197 , anthocyanins were absorbed and occurred in body fluids mainly in the form of methylated, glucuronid

198 The stability and abundance of miRNAs in body fluids make them attractive as potential biomarkers

199 However, the low bacteria concentration in body fluids makes it difficult to detect their character

200 by the pressurized nature of their internal body fluids, making typical physiological techniques inf

201 of advanced imaging, neurophysiological, and body fluid markers.

202 The abnormal level of thrombin in body fluids may lead to different diseases, such as rheu

203 of mixtures of synthetic analogues of common body fluid metabolites.

204 ed as a cancer biomarker, AMF secretion into body fluids might be closely related to metastases forma

205 Body fluid mutant DNA (mutDNA) may allow non-invasive id

206 Cerebrospinal fluid (CSF) is a body fluid of high clinical relevance and an important s

207 been found to be present in plasma and other body fluids of humans and mice in surprisingly high conc

208 mically, with toxins present in the sera and body fluids of infected animals, and toxemia is signific

209 V) is transmitted by direct contact with the body fluids of infected person and objects contaminated

210 and C. difficile toxin B (TcdB) in sera and body fluids of piglets and mice exposed to C. difficile

211 as established how miRNAs are transported in body fluids often within exosomes, which are small cell-

212 antibiotic loading and exposure of beads to body fluids on release kinetics are unclear.

213 The influence of body fluids on release was assessed using CaSO4 beads th

214 s on individual exosomes, derived from human body fluids or cell culture media.

215 ant step toward detection of PrP(CWD) in the body fluids or excreta of CWD-susceptible species.

216 ulturing Listeria monocytogenes from sterile body fluids or from products of conception.

217 miRNAome) were either expressed in multiple body fluids or not expressed at all.

218 blood and less often by PCR testing of other body fluids or serology and plaque-reduction neutralizat

219 ought in tumor extract samples but also from body fluids or stools rendering their content even more

220 based biomarker gets elevated or modified in body fluids or tissues.

221 out of catalytic and metabolic activities in body fluids or tissues.

222 evel exposure (direct contact with a corpse, body fluids, or a case with diarrhoea, vomiting, or blee

223 egree as to permit the identification of the body fluid origin of forensic biological stains using as

224 ples from protein mixtures of cell lysate or body fluid origin.

225 esult of both acute and chronic increases of body fluid osmolality.

226 ne also reduced the systemic accumulation of body fluids (p < 0.001) with a mean of 1,410 +/- 560 mL

227 direct sensing of analytes such as drugs in body fluids, pesticides in water and soil, etc.

228 conditions wherein significant variations in body fluid pH occur.

229 The detection of microRNA panels in body fluids promises early diagnosis of many diseases, i

230 We cultured blood and other normally sterile body fluids, reconfirmed and serotyped pneumococcal isol

231 w that neurofilament light concentrations in body fluids reflect pathology and symptoms in mouse mode

232 ard shift in the osmotic operating point for body fluid regulation.

233 leukocytes and free viral particles in this body fluid remain elusive.

234 Reliable diagnosis of disease using body fluids requires sensitive and accurate detection of

235 d extraction for sample preparation of human body fluids resulted in an assay that measured low part

236 lity to determine the species of origin of a body fluid sample is a very important and crucial part o

237 ng 454 sequencing on NCCR DNA amplified from body fluid samples (urine, plasma, and cerebrospinal flu

238 ction in 2D NMR data collection time for the body fluid samples can be achieved by this method, witho

239 Further evaluation of this assay using body fluid samples from a larger patient population is w

240 Analysis of microRNAs (miRNA) in tissue and body fluid samples has gained significant momentum as a

241 s) that operate in the presence of simulated body fluids SBF, human serum and blood enriched with eth

242 um after immersion of the glass in simulated body fluid (SBF) are reported and discussed.

243 ctor applying cyclical loading and simulated body fluid (SBF) perfusion.

244 ir surface upon their immersion in simulated body fluid (SBF) was checked using SEM and pH measuremen

245 as tested for ethanol oxidation in simulated body fluid (SBF) with ionic composition similar to human

246 atite (HA) during the degrading in simulated body fluid (SBF), with the strength of the scaffold decr

247 n, disease manifestation, and persistence in body fluids seen following ZIKV infection.

248 Among human body fluids, serum plays a key role for diagnostic tests

249 Patient body fluids showed an elevation in N-acetyl-D-mannosamin

250 ine is an important, noninvasively collected body fluid source for the diagnosis and prognosis of hum

251 undation for understanding the physiology of body fluid spaces.

252 al blood--in an attempt to identify putative body fluid-specific miRNAs.

253 is used to detect antimicrobial activity in body fluid specimens that have been inoculated on a filt

254 l types including healthy/patient tissue and body fluid specimens, cell lines and murine models as we

255 wide variety of forensic evidence, including body fluid stains, at the scene of a crime.

256 We isolated exosomes from various body fluids such as amniotic fluid, liver cirrhosis asci

257 idneys through urine but is also secreted in body fluids such as blood and saliva.

258 d cell counts can also be performed on human body fluids such as cerebrospinal fluid, synovial fluid,

259 assay as applied to other readily accessible body fluids such as exhaled breath condensate (EBC), sal

260 on of miRNAs can be found extracellularly in body fluids such as human blood plasma and cerebrospinal

261 specific nucleic acid sequences from complex body fluids such as saliva.

262 most cases, (2) persistence of the virus in body fluids such as semen and saliva for longer periods

263 that are capable of detecting biomarkers in body fluids such as serum are an important prerequisite

264 cteriovorus predation needs to work in human body fluids such as serum where predation dynamics may d

265 zing metabolites (small molecules <1 kDa) in body fluids such as urine and plasma using various spect

266 prostate cancer with greater specificity in body fluids such as urine or blood.

267 eraction, with other nano-objects present in body fluids, such as single and aggregated proteins.

268 Considering all body fluid test results, 50 (74.6%) of the 67 patients w

269 in the tears of vaccinated mice, the initial body fluid that contacts the parasite during infectious

270 8DSS solution, and then exposed to simulated body fluid that favors mineral deposition.

271 dium consists of a Portland cement/simulated body fluid that includes polyacrylic acid and polyvinylp

272 Our results establish semen as a body fluid that naturally contains amyloid fibrils that

273 ch as NiV can infect and disseminate through body fluids that are rich in complement activity.

274 s (EVs) are cell-derived vesicles present in body fluids that play an essential role in various cellu

275 ytokine receptors are normal constituents of body fluids that regulate peripheral cytokine and lympho

276 g of hundreds of metabolites from tissues or body fluids, that is, "metabolomics." Because metabolite

277 With attractive performance and the use of body fluids, the presented approach is a safe and sustai

278 f the value expected from detecting virus in body fluids, the standard proxy measure of infectiousnes

279 ers (ETCs) contain areas that are exposed to body fluids through the care of patients suspected or co

280 ls and is found essentially in all cells and body fluids, thymosin beta(4) has the potential for sign

281 evel of supplements and their metabolites in body fluids/tissues, and to measure the efficacy on anti

282 uencing (mNGS) test using cell-free DNA from body fluids to identify pathogens.

283 aminations and examined viral persistence in body fluids using RT-PCR.

284 ionship between sodium intake and changes in body fluid volume.

285 ecause the miRNA expression profile for each body fluid was different from that obtained from 21 huma

286 Accuracy of counts on body fluids was consistent with hand counting by a train

287 esence of cell-free miRNAs that circulate in body fluids was discovered.

288 Using DNA samples from body fluids, we demonstrate that TOP-PCR recovers minute

289 of detectable Zika virus (ZIKV) RNA in human body fluids, we prospectively assessed a cohort of newly

290 Measured deviations in body fluid were produced by using a separate, prospectiv

291 ompares well to the levels of the inosine in body fluids which are in the range 0-2.9 microM for pati

292 cancer-related miRs have been identified in body fluids, which make them remarkable noninvasive biom

293 R assay for the detection of E. rostratum in body fluids, which we used to confirm infections in 57 a

294 r derivatives get absorbed completely in the body fluid with no residue and with minimal toxic effect

295 nosorbent assay-like assay of cannabidiol in body fluids with a detection limit of ~0.25 ng/mL.

296 ular assay that can detect microorganisms in body fluids with high sensitivity without the need of cu

297 t challenges for isolating them from complex body fluids with high-throughput and high-purity.

298 Because of the orange discoloration of body fluids with higher doses of rifampicin it was not p

299 paraffin-embedded (FFPE) tissues and sterile body fluids with known diagnosis of IFD based on referen

300 say achieves successful cocaine detection in body fluids, with a limit of detection of 10.4, 18.4, an